HighQC™ Human (Parental) Head And Neck Cancer Stem Cell

Description

HighQC™ Human (Parental) Head And Neck Cancer Stem Cells are tumor-initiating cells derived from human head and neck cancer tissues. Morphologically, the cells display a small, round to spindle-like appearance and grow as adherent monolayers under defined serum-free conditions. They express characteristic cancer stem cell markers such as CD44 and CD133, which are strongly associated with tumorigenic potential and therapy resistance. These cells exhibit stem-like properties, including self-renewal, the ability to differentiate into heterogeneous tumor cell populations and various epithelial cell types present in head and neck malignancies, and demonstrate high tumorigenicity in vivo. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.